Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

U.S. News

NIAID Grant Awarded to Buffalo University for HIV/AIDS Research

October 9, 2008

The University of Buffalo's School of Pharmacy and Pharmaceutical Sciences on Tuesday announced that it has received a seven-year, $7.6 million grant from NIH's National Institute of Allergy and Infectious Diseases for HIV/AIDS research worldwide, Business First of Buffalo reports. The funding will be used to establish clinical pharmacology quality assurance programs and laboratories at the university's Pharmacotherapy Research Center and at the Translational Pharmacology Core in the New York State Center of Excellence in Bioinformatics and Life Sciences.

The grant money also will support in-country laboratory specialist training in areas with high HIV/AIDS burdens worldwide, as well as allow researchers to analyze HIV/AIDS clinical trials. The program will train as many as 200 clinical researchers annually and offer clinical audits and other services. Bruce Holm, University of Buffalo senior vice provost and executive director of the Center of Excellence, said the funding is "just the beginning" for many potential projects, adding, "Over the next year to year and a half, we will launch even more of these programs" (Drury, Business First of Buffalo, 10/7).

Although one focus of the fight against HIV/AIDS worldwide is on increasing antiretroviral drug access and conducting clinical trials, such trials need to be carried out in countries with the highest HIV/AIDS burdens worldwide, the Buffalo News reports. However, many countries highly affected by HIV/AIDS do not have adequate facilities or trained specialists, according to the News. To address the issue, the Buffalo program will provide training in pharmacology to researchers who conduct trials on experimental antiretrovirals. The program also will conduct on-site audits, provide HIV/AIDS information and establish a centralized Web site to provide global access to research data. "We are excited about this opportunity to use our expertise and facilities to help fight the global AIDS epidemic," Gene Morse, professor and associate dean for clinical and translational research, said (Rey, Buffalo News, 10/7).

Back to other news for October 2008

Advertisement


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2008 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More HIV News

Tools
 

Advertisement